Recombinant antibodies have become important tools in biomedical research, diagnostics, therapeutic development, and biotechnology. Unlike antibodies produced directly from traditional hybridoma systems, recombinant antibodies are generated using engineered genetic sequences that encode a desired antibody. This approach provides greater control over antibody sequence, consistency, and production. For organizations developing research or therapeutic antibodies, understanding the production workflow can help determine which expression system, purification strategy, and quality controls are appropriate for a particular application. What Is Recombinant Antibody Production? Recombinant antibody production involves using recombinant DNA technology to express an antibody or antibody fragment in a suitable host system. The genes encoding the antibody's heavy and light chains are introduced into host cells, which then produce the desired antibody. Key point: The production process can be...